Sabahat Bokhari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sabahat Bokhari has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Deniz Alibazoglu
Northwestern University, Chicago, USA
1 shared publication - Haluk Alibazoglu
Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates
1 shared publication - Hani Sabbour
Warren Alpert Medical School, Brown University, Providence, RI, USA
1 shared publication - Ingy Romany
Pfizer Gulf FZ-LLC, Dubai, United Arab Emirates
1 shared publication - Yehuda Edo Paz
Columbia University Medical Center
1 shared publication - Zainab Al Taha
Sheikh Shakhboot Medical City, Abu Dhabi, United Arab Emirates
1 shared publication
Latest Publications
- Open Access
- 1 March 2023
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 30 (5) , 1922-1934
Attacking the Achilles heel of cardiac amyloid nuclear scintigraphy: How to reduce equivocal and false positive studies
- 1 March 2023
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 30 (5) , 1922-1934
Open AccessAttacking the Achilles heel of cardiac amyloid nuclear scintigraphy: How to reduce equivocal and false positive studies
- 30 November 2013
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 30 (2) , 431-438
The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy
Substantial literature exists linking inflammation with arrhythmia, in particular with regards to serological markers of systemic inflammation. Regional inflammation can be identified using positron emission tomography (PET) with the radiotracer F18-fluorodeoxyglucose (F18-FDG). In the current series, we demonstrate novel applications of cardiac PET using F18-FDG and N13-ammonia radiotracers in the evaluation and treatment of arrhythmia associated with cardiac sarcoidosis. These applications include defining the cause of arrhythmia, identifying arrhythmias that will be amenable to medical management, and guiding therapy using serial scanning. Though these applications are promising, prospective multicenter studies are needed to provide better understanding of the utility of PET imaging in the diagnosis and treatment of arrhythmias.
- 30 November 2013
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 30 (2) , 431-438
The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy
Substantial literature exists linking inflammation with arrhythmia, in particular with regards to serological markers of systemic inflammation. Regional inflammation can be identified using positron emission tomography (PET) with the radiotracer F18-fluorodeoxyglucose (F18-FDG). In the current series, we demonstrate novel applications of cardiac PET using F18-FDG and N13-ammonia radiotracers in the evaluation and treatment of arrhythmia associated with cardiac sarcoidosis. These applications include defining the cause of arrhythmia, identifying arrhythmias that will be amenable to medical management, and guiding therapy using serial scanning. Though these applications are promising, prospective multicenter studies are needed to provide better understanding of the utility of PET imaging in the diagnosis and treatment of arrhythmias.